0001225208-16-041461.txt : 20161110 0001225208-16-041461.hdr.sgml : 20161110 20161110172914 ACCESSION NUMBER: 0001225208-16-041461 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161109 FILED AS OF DATE: 20161110 DATE AS OF CHANGE: 20161110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRAZIER KENNETH C CENTRAL INDEX KEY: 0001181175 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 161989281 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 4 1 doc4.xml X0306 4 2016-11-09 0000310158 Merck & Co., Inc. MRK 0001181175 FRAZIER KENNETH C MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 1 Chairman, President & CEO Common Stock 2016-11-09 4 M 0 6080.0000 23.4500 A 514957.0630 D Common Stock 2016-11-09 4 S 0 6080.0000 65.0000 D 508877.0630 D Common Stock 2016-11-10 4 M 0 133920.0000 23.4500 A 642797.0630 D Common Stock 2016-11-10 4 S 0 133920.0000 65.0335 D 508877.0630 D Common Stock - 401(k) Plan 3750.4977 I By 401(k) Stock Option (right to buy) 23.4500 2016-11-09 4 M 0 6080.0000 0.0000 D 2010-04-24 2019-04-23 Common Stock 6080.0000 133920.0000 D Stock Option (right to buy) 23.4500 2016-11-10 4 M 0 133920.0000 0.0000 D 2010-04-24 2019-04-23 Common Stock 133920.0000 0.0000 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.0000 to $65.1900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Holdings include shares acquired in dividend reinvestment transactions. Includes shares acquired and dividends earned through October 7, 2016, in the Merck U.S. Savings Plan, a 401(k) plan. The option became exercisable in equal installments on 4/24/2010, 4/24/2011 and 4/24/2012. Katie Fedosz as Attorney-in-Fact for Kenneth C. Frazier 2016-11-10